Product
Loperamide
Aliases
Imodium
13 clinical trials
26 indications
Indication
Breast NeoplasmsIndication
Breast CancerIndication
Colorectal CancerIndication
Solid TumorIndication
Glioblastoma MultiformeIndication
Healthy ParticipantsIndication
DiarrhoeaIndication
Traveler's DiarrheaIndication
Low Anterior Resection SyndromeIndication
Rectal cancerIndication
HER2-positive breast cancerIndication
Hormone Receptor PositiveIndication
Endometrial CancerIndication
Ovarian CancerIndication
Breast Cancer (HER2-positive)Indication
Breast Cancer, Stage IIAIndication
Stage III Breast CancerIndication
Stage IIIA Breast CancerIndication
DiarrheaIndication
ColitisIndication
Malignant Genitourinary System NeoplasmIndication
MelanomaIndication
lung cancerIndication
Uterine CancerIndication
Cervical CancerClinical trial
A Phase 1b Study of Abemaciclib in Combination With Therapies for Patients With Metastatic Breast CancerStatus: Active (not recruiting), Estimated PCD: 2021-03-15
Clinical trial
A Phase 2 Study of Poziotinib in Patients With EGFR or HER2 Activating Mutations in Advanced MalignanciesStatus: Terminated, Estimated PCD: 2022-03-29
Clinical trial
A Randomized, Open-Label, Phase 2 Study of Abemaciclib Plus Tamoxifen or Abemaciclib Alone, in Women With Previously Treated Hormone Receptor-Positive, HER2-Negative, Metastatic Breast CancerStatus: Active (not recruiting), Estimated PCD: 2018-06-15
Clinical trial
A Single-centre, Open, Single-dose, Fixed-sequence Study to Investigate the Effect of Montmorillonite Power or Loperamide on the Pharmacokinetics of Pyrotinib in Healthy Chinese Adult SubjectsStatus: Completed, Estimated PCD: 2022-08-02
Clinical trial
An Open-Label Phase 2 Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With NeratinibStatus: Completed, Estimated PCD: 2021-12-28
Clinical trial
A Single Center, Single Arm, Open and Fixed Sequence Study to Investigate the Pharmacokinetic Effects of Loperamide on Pyrotinib Maleate in Healthy SubjectsStatus: Completed, Estimated PCD: 2020-04-30
Clinical trial
A Randomized Controlled Trial Evaluating Single-dose Rifaximin Versus Azithromycin With Loperamide Adjunct for Treatment of Acute Watery DiarrheaStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Low Anterior Resection Syndrome: Retrograde Enema Program vs Medical ManagementStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Randomized Phase II Study to Evaluate the Incidence of Discontinuations Due to Diarrhoea at 3 Cycles in Patients With Early-stage HER2-positive (HER2+), Hormone Receptor-positive (HR+) Breast Cancer Treated With Neratinib Plus Loperamide Prophylaxis Versus Neratinib With Initial Dose Escalation Plus PRN Loperamide Prophylaxis Versus Neratinib Plus Loperamide Plus Colesevelam Prophylaxis "DIANER Study"Status: Recruiting, Estimated PCD: 2025-03-25
Clinical trial
4FMFES Positron Emission Tomography (PET) for Detection of Newly-diagnosed ER+ Endometrial and Ovarian CancersStatus: Completed, Estimated PCD: 2023-08-31
Clinical trial
An Open Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With HER2+ Breast Cancer Treated With Neratinib With or Without TrastuzumabStatus: Completed, Estimated PCD: 2022-10-31
Clinical trial
Randomized Trial of High-Dose Versus Conventional Dose Octreotide Acetate Versus Loperamide in the Treatment of Chemotherpay-Related Diarrhea in Patients With Colorectal CancerStatus: , Estimated PCD: 2000-05-01
Clinical trial
Fecal Microbiota Transplantation (FMT) for Immune-Checkpoint Inhibitor Induced-Diarrhea/Colitis in Genitourinary Cancer PatientsStatus: Recruiting, Estimated PCD: 2025-12-31